companydata.dkInnosurge Biologics A/S: Financial statements 2021
CVR: 38768964
Innosurge Biologics A/S (CVR 38768964) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 992,732 and a net result of DKK -613,437 compared with DKK -2,600,178 the year before. Equity amounted to DKK 836,382. The solvency ratio was 22%. The company had 3 employees in the financial year.
- Gross Profit
- 992,732 kr.
- Profit/Loss
- -613,437 kr.
- Equity
- 836,382 kr.
- Total Assets
- 3,805,641 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 993 t. | -613 t. | 836 t. | 3 |
| 2020 | - | -695 t. | -2.6 mio. | 1.4 mio. | 3 |
| 2019 | - | 1.2 mio. | 290 t. | 2 mio. | 2 |
| 2018 | - | 1.7 mio. | 799 t. | 1.8 mio. | 1 |
Find more companies like Innosurge Biologics A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Innosurge Biologics A/S has published its annual report for 2020. Gross profit came to DKK -695,490, and the net result was DKK -2,600,178.
About Innosurge Biologics A/S
Innosurge Biologics A/S is a Danish company of the type Aktieselskab based in Randers NV, founded in 2017. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Peter Møller Lassen. The company is owned by CMA HOLDING RANDERS ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 4,455,235 and a net result of DKK 1,662,593 compared with DKK 251,617 the year before. Equity amounted to DKK 2,897,096.